Study Title: A Phase II Study of Adjuvant Treatment With Cisplatin-based Chemotherapy Plus Concomitant Atezolizumab in Patients With Stage I (Tumors ≥ 4cm), IIA, IIB, and Select IIIA [T3N1, T4N0-1] Resected Non-small Cell Lung Cancer (NSCLC) and the Clearance of Circulating Tumor DNA (ctDNA) Big Ten Cancer Research Consortium BTCRC-LUN19-396
 

• Closed to Accrual at:
  • Indiana University Melvin and Bren Simon Comprehensive Cancer Center
  • Robert H. Lurie Comprehensive Cancer Center of Northwestern University
  • The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute 
  • Penn State Cancer Institute
  • Rutgers Cancer Institute of New Jersey
  • University of Wisconsin Carbone Cancer Center
  • New York University Perlmutter Cancer Center
  • Summit Health
  • University of Virginia 
• Learn more:
  • clinicaltrials.gov: NCT04367311
• Publications and Presentations:
  • Poster: IASLC World Conference on Lung Cancer 2020
  • Trials in Progress: 2022 ASCO Annual Meeting 

Study Contact: studies@hoosiercancer.org; (317) 921-2050.